Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

AKT as a therapeutic target in multiple myeloma.

AKT as a therapeutic target in multiple myeloma. Expert Opin Ther Targets. 2014 Aug; 18(8):897-915.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.